What are the implications of cost for myeloma therapy?

Expert Rev Hematol. 2019 Dec;12(12):1005-1009. doi: 10.1080/17474086.2019.1682545. Epub 2019 Oct 31.

Authors

Tianqi Xu¹, Wenhui Yang², Ligang Chen³, Guangxun Gao¹

Affiliations

¹ Department of Haematology, People's Liberation Army Centre for Haematologic Disorders, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, P.R. China.
² Department of Respiratory, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, P.R. China.
³ Department of Neurosurgery, General Hospital of Northern Military Area, Shenyang, China.

PMID: 31625767
DOI: 10.1080/17474086.2019.1682545

No abstract available

Keywords: cost; cost-effectiveness; financial burden; haematology; multiple myeloma.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Costs and Cost Analysis
Humans
Multiple Myeloma / economics*
Multiple Myeloma / therapy*